Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
BlackBerry
BB
$5.12B
| $963K | ﹤0.01% |
295,432
+135,724
| +85% | +$602K |
|
2777
Edgewell Personal Care
EPC
$1.35B
| $963K | ﹤0.01% |
24,986
-19,372
| -44% | -$769K |
|
|
WSR
2778
DELISTED
Whitestone REIT
WSR
| $963K | ﹤0.01% |
99,845
+7,536
| +8% | +$69.4K |
|
2779
Grab
GRAB
$15.3B
| $962K | ﹤0.01% |
298,813
+43,857
| +17% | +$126K |
|
2780
LeMaitre Vascular
LMAT
$1.81B
| $961K | ﹤0.01% |
20,879
-346
| -2% | -$16.2K |
|
2781
GFL Environmental
GFL
$14.9B
| $959K | ﹤0.01% |
32,795
-26,354
| -45% | -$715K |
|
2782
Kratos Defense & Security Solutions
KTOS
$10.4B
| $958K | ﹤0.01% |
92,841
+21,240
| +30% | +$211K |
|
2783
Globus Medical
GMED
$10.9B
| $955K | ﹤0.01% |
12,861
-6,634
| -34% | -$452K |
|
2784
Minerals Technologies
MTX
$2.4B
| $952K | ﹤0.01% |
15,685
+7,245
| +86% | +$411K |
|
2785
Envista
NVST
$4.66B
| $951K | ﹤0.01% |
28,238
-29,714
| -51% | -$1.02M |
|
2786
America's Car Mart
CRMT
$28.4M
| $951K | ﹤0.01% |
13,155
+2,817
| +27% | +$191K |
|
2787
Graham Holdings Company
GHC
$5.14B
| $950K | ﹤0.01% |
1,572
+1,414
| +895% | +$862K |
|
2788
TTM Technologies
TTMI
$13.6B
| $950K | ﹤0.01% |
62,976
+5,739
| +10% | +$85.1K |
|
2789
Ducommun
DCO
$2.89B
| $948K | ﹤0.01% |
18,980
+2,488
| +15% | +$118K |
|
2790
Energizer
ENR
$1.54B
| $945K | ﹤0.01% |
28,171
+20,074
| +248% | +$617K |
|
2791
Team
TISI
$78M
| $944K | ﹤0.01% |
179,724
+27,463
| +18% | +$209K |
|
2792
Atara Biotherapeutics
ATRA
$76.9M
| $943K | ﹤0.01% |
11,497
-2,328
| -17% | -$243K |
|
|
SPWR
2793
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $939K | ﹤0.01% |
+52,100
| New | +$1.07M |
|
2794
Embecta
EMBC
$212M
| $939K | ﹤0.01% |
37,141
+14,133
| +61% | +$432K |
|
|
TWNI
2795
DELISTED
Tailwind International Acquisition Corp.
TWNI
| $939K | ﹤0.01% |
93,046
-33,787
| -27% | -$338K |
|
|
CHCT
2796
Community Healthcare Trust
CHCT
$440M
| $938K | ﹤0.01% |
26,201
+7,885
| +43% | +$269K |
|
2797
Washington Trust Bancorp
WASH
$753M
| $936K | ﹤0.01% |
19,835
+4,991
| +34% | +$240K |
|
2798
PUT
Carvana
CVNA
$76.4B
| $936K | ﹤0.01% |
987,000
+726,000
| +278% | +$1.53M |
|
|
HTT
2799
High Templar Tech Ltd
HTT
$398M
| $935K | ﹤0.01% |
981,160
-549,000
| -36% | -$481K |
|
2800
Coherent
COHR
$64.2B
| $934K | ﹤0.01% |
26,612
-32,264
| -55% | -$1.12M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.